FDA NDC Directory · JSON-LD · Markdown

CITALOPRAM

NDC 59651-964 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAurobindo Pharma Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA219985
Dosage form / routeCAPSULE · ORAL
Active ingredientsCITALOPRAM HYDROBROMIDE (30 mg/1)
Marketing started20260313
Package count1

External sources

Source: openFDA. Public-domain (CC0).